In a move set to address the critical scalability challenges facing the biotechnology sector, Pow.Bio and Bühler Group have formed a strategic partnership to launch an integrated continuous precision fermentation platform.
The collaboration merges Pow.Bio’s AI-driven continuous fermentation technology with Bühler’s global engineering capabilities and advanced model-driven control software. The resulting platform is designed to replace traditional batch and fed-batch methods, aiming to significantly reduce unit production costs while enhancing process consistency and productivity.
Operational Advantages and Target Market
The new solution is specifically engineered to smooth the transition from laboratory environments to pilot and industrial-scale production. It targets manufacturers of fermentation-derived products—including enzymes, organic acids, functional proteins, speciality lipids, and bioactive compounds—who currently struggle with the cost and output limitations of conventional systems.
By enabling a continuous, model-driven process, the platform promises to unlock commercial-scale production with reduced risk and unprecedented efficiency.
Strategic Impact on the Food Industry
Thierry Duvanel, Bühler’s North American Director of Innovation, emphasised the potential of the technology to reshape ingredient production.
"Precision fermentation has the potential to impact the food, feed, and speciality ingredients industries. Companies are already using it to produce dairy, meat and egg substitutes, alternative oils and fats and even novel pet food – and we are only at the beginning of what this technology can unlock," Duvanel stated.
He added: "By joining forces with Pow.Bio, we take a clear step toward reducing unit production costs in biomanufacturing, combining complementary expertise to accelerate innovation and deliver a fully integrated system backed by experience, service and reliability.”
Shannon Hall, CEO and co-founder of Pow.Bio, highlighted the competitive advantage the partnership offers to clients.
“Our collaboration with Bühler sets a new benchmark for biomanufacturing: not just faster, but smarter and more robust," Hall said. "Clients can now capitalise on proven technology and global deployment expertise to unlock commercial-scale production with lower risk and unprecedented efficiency."
She concluded: "This partnership solidifies Pow.Bio’s position at the forefront of industrial biotechnology, enabling us to deliver enduring value for our clients and the sector as a whole.”
Pow.Bio and Bühler Unite to Lower Biomanufacturing Costs with Continuous Fermentation Platform
